NCT00313989

Brief Summary

Follow up of implants with patients receiving radiotherapy for buccopharyngeal oncology. Implants will be placed 6 weeks before start of the radiotherapy or at least 3 months after the end of the radiotherapy

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Sep 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 11, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 12, 2006

Completed
1.4 years until next milestone

Study Start

First participant enrolled

September 1, 2007

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

December 21, 2022

Status Verified

December 1, 2014

Enrollment Period

7.9 years

First QC Date

April 11, 2006

Last Update Submit

December 19, 2022

Conditions

Dental Implants

Outcome Measures

Primary Outcomes (2)

  • Recovering and ingrowing of dental implants

    4 to 6 months

  • Success rate of dental implants

    4 to 6 months

Study Arms (1)

Evaluation of implants of patients receiving radiotherapy.

EXPERIMENTAL
Procedure: Evaluation of the success rate of implants

Interventions

Evaluation of the success rate of implantsPROCEDURE

Evaluation of the success rate of implants

Evaluation of implants of patients receiving radiotherapy.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients receiving radiotherapy (6 weeks later or at least 3 months before) for buccopharyngeal oncology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ghent

Ghent, 9000, Belgium

Location

Related Links

Study Officials

  • Hugo De Bruyn, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2006

First Posted

April 12, 2006

Study Start

September 1, 2007

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

December 21, 2022

Record last verified: 2014-12

Locations

BE(1)